Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Protein nano-drug for cancer targeted therapy and preparation method thereof

A nano-drug, targeted therapy technology, applied in the field of biomedicine, can solve problems such as lack of research, achieve the effect of maintaining integrity, promoting tumor growth and migration, and improving drug delivery efficiency

Active Publication Date: 2020-11-10
SOUTH CHINA NORMAL UNIVERSITY
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, research in this area is lacking

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Protein nano-drug for cancer targeted therapy and preparation method thereof
  • Protein nano-drug for cancer targeted therapy and preparation method thereof
  • Protein nano-drug for cancer targeted therapy and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0105] Example 1 Preparation of TPP / p53@Exos

[0106] 1. Preparation and characterization of TPP / p53

[0107] 1. Experimental method

[0108] (3-Propylcarboxy)-triphenylphosphine bromide was dissolved in hot phosphate buffered saline (PBS, pH=6.2) to obtain a TPP saturated solution with a concentration of about 0.46 mg / mL; EDC and NHS (20 : 1, n / n), activate the carboxyl group of TPP, and react for about 15 min; add p53 solution (0.6 mg / mL) to the activated TPP solution (~1:1000, n / n), react at room temperature for 2 h, Synthesize TPP / p53; add β-mercaptoethanol to quench EDC (1:1, n / n) for 5min; transfer the reaction solution to a dialysis bag (1000Da), and dialyze it in PBS dialysate for 24h.

[0109] By FT-IR Fourier infrared spectroscopy and 1 The chemical bond changes of TPP / p53 were detected by H-NMR spectroscopy. The secondary structure of recombinant p53 was detected by circular dichroism. Use an ultraviolet spectrophotometer (UV-1800) to scan the maximum absorptio...

Embodiment 2

[0133] Example 2 Cellular uptake and mitochondrial targeting characterization of TPP / p53@Exos

[0134] 1. Experimental method

[0135] The cellular uptake and mitochondria-targeted delivery of the nanodrug delivery system TPP / p53@Exos were observed by immunofluorescence. The exosomes secreted by MCF-7 and SK-BR-3 were purified to prepare TPP / p53@Exos, respectively. MCF-7 and SK-BR-3 cells were treated with two cell-derived TPP / p53@Exos, respectively, at 37°C, 5% CO 2 Incubate in a constant temperature incubator for 2 h; fix cells with pre-cooled 4% paraformaldehyde at room temperature for 15 min; use TBS triethanolamine buffered saline solution to permeate the membrane for 5 min; incubate with CD63 primary antibody (diluted 1:100) to label exosomes , 4°C overnight; use FITC fluorescent secondary antibody (diluted 1:1000) to incubate at room temperature for 1 h; use DAPI staining solution (diluted 1:1000) to incubate cells at room temperature for 10 min to stain cell nuclei; ...

Embodiment 3

[0141] Example 3 Toxicity characterization of TPP / p53@Exos on syngeneic cancer cells

[0142] 1. Experimental method

[0143] (1) CCK-8 assay was used to detect the growth inhibitory effect of TPP / p53@Exos on cancer cells. Follow 1×10 4Cell density MCF-7 (ER+, PR+, HER2-) cells were seeded on 96-well plates and incubated overnight; free p53 protein, MCF-7-derived empty exosome mExos, TPP / p53 recombinant protein and TPP were respectively / p53@mExos nano-drug delivery system (equal p53 molar amount, 600ng / well) acted on MCF-7 cells for 24h; in order to detect the affinity effect of nano-drug delivery system on homologous breast cancer cell lines, p53 mutant breast cancer The cell line SK-BR-3 (ER-, PR-, HER2+) was used as a control, and the same treatment was applied with TPP / p53@mExos; CCK-8 cell viability detection kit working solution was added for incubation, and a microplate reader (ThermoFisher MK3) was used. The absorbance of cells at a wavelength of 450 nm was measure...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a protein nano-drug for cancer targeted therapy and a preparation method thereof. The protein nano-drug is an exosome of humanized p53 protein transferred with covalent cross-linked triphenylphosphine (TPP). A protein nano-drug delivery system TPP / p53@Exos developed by the invention can recognize specific cancer cells in a targeted manner, efficiently inhibits the growth ofthe cancer cells by activating endogenous apoptosis pathways of the cells, has no toxic or side effect, and provides a new means for cancer treatment. The preparation method of the nano-drug deliverysystem has a high protein loading rate (about 75%), and can also be used for protection and targeted delivery of other protein drugs.

Description

technical field [0001] The invention relates to the technical field of biomedicine, and more particularly, to a protein nanomedicine for cancer targeted therapy and a preparation method thereof. Background technique [0002] With increasing morbidity and mortality, cancer has become the leading cause of death and a major public health problem in China. [0003] Chemotherapy and radiotherapy, as the most mainstream cancer treatment methods at present, face the problem of drug resistance of cancer cells and toxic side effects to the body. Cancer stem cells (CSCs) can effectively evade clearance by chemotherapy and radiotherapy by expressing ATP-binding cassette (ABC) transporters, anti-apoptotic proteins, and DNA repair enzymes, leading to drug resistance and tumor recurrence. However, small molecular weight based chemotherapeutics (alkylating agents, anthracyclines, microtubule inhibitors, antimetabolites, platinum drugs, topoisomerase inhibitors, tyrosine kinase inhibitors ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/42A61K47/46A61P35/00B82Y5/00
CPCA61K47/42A61K47/46A61P35/00B82Y5/00
Inventor 关燕清张令坤焦宇萱唐云志
Owner SOUTH CHINA NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com